Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
2012 · Nature · 909 citations
https://doi.org/10.1038/nature11378
S
Stefania Pittaluga
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
778
Papers
45.4K
Citations
116
h-index
374
i10-index
Stefania Pittaluga is an academic researcher from New York University. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Viral-associated cancers and disorders. The author has an h-index of 116, co-authored 662 publications.
ORCID: 0000-0001-7688-1439Papers by this author
worksThe lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
2010 · Blood · 811 citations
https://doi.org/10.1182/blood-2010-05-284984
SARS-CoV-2 infection of the oral cavity and saliva
2021 · Nature Medicine · 807 citations
https://doi.org/10.1038/s41591-021-01296-8
Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series
2020 · EClinicalMedicine · 558 citations
https://doi.org/10.1016/j.eclinm.2020.100434
Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections
2010 · PLoS Pathogens · 465 citations
https://doi.org/10.1371/journal.ppat.1001052
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study
2018 · The Lancet Haematology · 226 citations
https://doi.org/10.1016/s2352-3026(18)30177-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat